Healthcare Value Screen and Top Stock Ranking
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Healthcare Value Screen and Top Stock Ranking
-
ナレーター：
-
著者：
このコンテンツについて
This episode provides a detailed value investing analysis of ten major healthcare stocks, stemming from an initial inquiry into undervalued opportunities within the sector. It introduces a comprehensive, multi-step quantitative and qualitative screening template designed to identify true value, focusing on metrics like P/E, cash flow, balance sheet strength, and business quality. The stocks were ranked using a 30-point scoring system, but the analysis then incorporates refinements by explicitly adding a Dividend Strength component and later an Improving Regulatory & Financial Climate factor, ultimately leading to a 35-point scoring framework. The high-conviction recommendation names AbbVie (ABBV), Molina Healthcare (MOH), and Pfizer (PFE) as the top three holdings, each selected for complementary reasons such as income, compounding, and potential for mispricing correction.